Renu Gupta

An adjuvant autologous therapeutic vaccine (HSPPC-96; vitespen) versus observation alone for patients at high risk of recurrence after nephrectomy for renal cell carcinoma: a multicentre, open-label, randomised phase III trial

Christopher G. Wood, Pramod K. Srivastava, Ronald M. Bukowski et al. · The Lancet · 2008 · 330 citations

Medicine, Immunology, Oncology +16

Phase III Comparison of Vitespen, an Autologous Tumor-Derived Heat Shock Protein gp96 Peptide Complex Vaccine, With Physician's Choice of Treatment for Stage IV Melanoma: The C-100-21 Study Group

Alessandro Testori, Jon Richards, Eric D. Whitman et al. · Journal of Clinical Oncology · 2008 · 254 citations

Medicine, Oncology, Pharmacology +15

Randomized Trial of Liposomal Amikacin for Inhalation in Nontuberculous Mycobacterial Lung Disease

Kenneth N. Olivier, David E. Griffith, Gina Eagle et al. · American Journal of Respiratory and Critical Care Medicine · 2016 · 246 citations

Pharmacy, Infectious Diseases, Pharmacology +17

Effect of Recombinant Human Pentraxin 2 vs Placebo on Change in Forced Vital Capacity in Patients With Idiopathic Pulmonary Fibrosis

Ganesh Raghu, Bernt van den Blink, Mark J. Hamblin et al. · JAMA · 2018 · 225 citations · Full text

Health Professions, Pharmacology, Pharmacotherapy +17

Phase II studies of nebulised Arikace in CF patients with<i>Pseudomonas aeruginosa</i>infection

John P. Clancy, Lieven Dupont, Michael W. Konstan et al. · Thorax · 2013 · 219 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +15